E-ISSN: 3023-6215
Do Hematological Parameters Have a Significant Role in Predicting the Results of Prostate Biopsies?
PDF
Cite
Share
Request
Clinical Research
VOLUME: 30 ISSUE: 1
P: 34 - 38
2020

Do Hematological Parameters Have a Significant Role in Predicting the Results of Prostate Biopsies?

Anatol J Gen Med Res 2020;30(1):34-38
Ali Borekoglu 1
Deniz Abat 2
Huseyin Eren 3
Adem Altunkol 4
Onur Karslı 5
Selçuk Yaylacı 6
1. University Of Health Sciences, Mersin City Teaching And Research Hospital,department Of Urology, Mersin, Turkey
2. Ministry Of Health, Iskenderun State Hospital, Hatay, Turkey
3. Recep Tayyip Erdoğan University, Faculty Of Medicine, Department Of Urology, Rize, Turkey
4. University Of Health Sciences, Adana City Teaching And Research Hospital,department Of Urology, Adana, Turkey
5. University Of Health Sciences, Derince Teaching And Research Hospital, Department Of Urology, Kocaeli, Turkey
6. Sakarya University, Faculty Of Medicine, Department Of Internal Medicine, Sakarya, Turkey
No information available.
No information available
Received Date: 2019-04-09T22:43:36
Accepted Date: 2020-04-01T17:50:01
PDF
Cite
Share
Request

Abstract

INTRODUCTION

To assess the predictive role of hematological parameters on the results of prostate biopsies.

METHODS

We evaluated patients who underwent ultrasound-guided prostate biopsies between January 2014 and April 2016. The patients were divided into two groups according to their histopathological results: patients with prostate detected cancer and patients without detected cancer. The erythrocyte count, neutrophil count, lymphocyte count, platelet count, hemoglobin level, hematocrit, red cell distribution width, mean platelet volume, platelet distribution width and plateletcrit were analyzed before biopsy. Additionally, neutrophil-to-lymphocyte ratios and platelet-to-lymphocyte ratios were calculated. These parameters were compared between the two groups and statistically analyzed.

RESULTS

Prostate cancer was detected in 38 (30.25%) patients, and benign conditions (prostatic hyperplasia or chronic prostatitis) were detected in 88 (69.85%) patients. There was no statistically significant difference between the patients with prostate cancer and patients with benign conditions according to the erythrocyte count, neutrophil count, lymphocyte count, platelet count, hemoglobin level, hematocrit, red cell distribution width, mean platelet volume and platelet distribution width and plateletcrit. Additionally, there were no statistically significant differences between the groups regarding the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio.

DISCUSSION AND CONCLUSION

Hematological parameters play no significant role in predicting prostate biopsy results. More sophisticated studies are needed to further evaluate this issue.

Keywords:
Biopsy, Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Prostate
2024 ©️ Galenos Publishing House